| Dayna Rutkoski, CRNP | |
|
100 N Academy Ave, Danville, PA 17822-9800 | |
| (570) 271-6550 | |
| (570) 271-5879 |
| Full Name | Dayna Rutkoski |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 100 N Academy Ave, Danville, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033846597 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LN0000X | Nurse Practitioner - Neonatal | SP026013 (Pennsylvania) | Secondary |
| 363L00000X | Nurse Practitioner | SP026013 (Pennsylvania) | Primary |
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
CongressDaily reports that when members of Congress return to Washington Monday "they face a raft of unfinished business on tax 'extender' legislation. … The Senate will look to take up a $114.5 billion package of unemployment benefits, tax breaks, physician payments and other provisions this week amid calls from the right to scale it back, from the left to expand it and from businesses to mitigate its tax increases.
Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Ondansetron Injection USP, 2 mg/mL, Multi-Dose Vials. Ondansetron Injection USP, 2 mg/mL is the generic equivalent of GlaxoSmithKline's Zofran® Injection, 2 mg/mL. For the 12 months ending December 2009 U.S. sales of Ondansetron Injection USP, 2 mg/mL were approximately $58 million at Average Wholesale Price (AWP). A launch date for the product has not yet been set.
New research from the University of Oxford and the UK Centre for Ecology & Hydrology, published today in Frontiers in Public Health, uses mathematical modeling to determine the most equitable way to share vaccines between nations.
Researchers in Warwick Medical School at the University of Warwick have developed a way to create more crucial reagents for use in COVID-19 tests that could also provide enhancements to the use of, and production of, future tests.
The World health statistics 2012 report, released today, puts the spotlight on the growing problem of the noncommunicable diseases burden.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dayna Rutkoski, CRNP 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dayna Rutkoski, CRNP 100 N Academy Ave, Danville, PA 17822-9800 Ph: (570) 271-6550 |
News Archive
CongressDaily reports that when members of Congress return to Washington Monday "they face a raft of unfinished business on tax 'extender' legislation. … The Senate will look to take up a $114.5 billion package of unemployment benefits, tax breaks, physician payments and other provisions this week amid calls from the right to scale it back, from the left to expand it and from businesses to mitigate its tax increases.
Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Ondansetron Injection USP, 2 mg/mL, Multi-Dose Vials. Ondansetron Injection USP, 2 mg/mL is the generic equivalent of GlaxoSmithKline's Zofran® Injection, 2 mg/mL. For the 12 months ending December 2009 U.S. sales of Ondansetron Injection USP, 2 mg/mL were approximately $58 million at Average Wholesale Price (AWP). A launch date for the product has not yet been set.
New research from the University of Oxford and the UK Centre for Ecology & Hydrology, published today in Frontiers in Public Health, uses mathematical modeling to determine the most equitable way to share vaccines between nations.
Researchers in Warwick Medical School at the University of Warwick have developed a way to create more crucial reagents for use in COVID-19 tests that could also provide enhancements to the use of, and production of, future tests.
The World health statistics 2012 report, released today, puts the spotlight on the growing problem of the noncommunicable diseases burden.
› Verified 9 days ago
Ms. Patricia A. Porter, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6028 Fax: 570-271-5845 | |
Ms. Cynthia G. Kline, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6621 | |
Ms. Megan M. Gusick, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6437 Fax: 570-271-6663 | |
Ms. Mary A. Connell, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6028 Fax: 570-271-5845 | |
Mrs. Jennifer M Bennett, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 175 Northumberland Street, Danville, PA 17821 Phone: 570-284-4575 Fax: 570-284-4577 | |
Ms. Maria M. Urick, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-8050 Fax: 570-271-5940 |